+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Atopic Keratoconjuctivitis - Pipeline Insight, 2025 - Product Thumbnail Image

Atopic Keratoconjuctivitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Community Acquired Uncomplicated UTI - Pipeline Insight, 2025 - Product Thumbnail Image

Community Acquired Uncomplicated UTI - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
WHIM Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

WHIM Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Dense Deposit Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Dense Deposit Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Drug Hypersensitivity - Pipeline Insight, 2025 - Product Thumbnail Image

Drug Hypersensitivity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
EGFR Inhibitors Induced Skin Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

EGFR Inhibitors Induced Skin Disorders - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Female Trichomoniasis Vaginalis - Pipeline Insight, 2025 - Product Thumbnail Image

Female Trichomoniasis Vaginalis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Obesity - Pipeline Insight, 2025 - Product Thumbnail Image

Obesity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Gluten Sensitivity - Pipeline Insight, 2025 - Product Thumbnail Image

Gluten Sensitivity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Hearing Loss- Pipeline Insight, 2025 - Product Thumbnail Image

Hearing Loss- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Hemolytic Disease Of The Fetus And Newborn - Pipeline Insight, 2025 - Product Thumbnail Image

Hemolytic Disease Of The Fetus And Newborn - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Inguinal Hernia - Pipeline Insight, 2025 - Product Thumbnail Image

Inguinal Hernia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Kabuki Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Kabuki Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lymphocytopenia- Pipeline Insight, 2025 - Product Thumbnail Image

Lymphocytopenia- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Maple Syrup Urine Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Maple Syrup Urine Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
MOG Antibody Disease - Pipeline Insight, 2025 - Product Thumbnail Image

MOG Antibody Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Mouth & Throat Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Mouth & Throat Pain - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Myofibroblasts - Pipeline Insight, 2025 - Product Thumbnail Image

Myofibroblasts - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more